Desenvolvimento de uma vacina tetravalente contra dengue

Guy, Bruno; Saville, Melanie; Lang, Jean; Siqueira Jr, João Bosco; Bricks, Lucia Ferro.
Rev. Pan-Amazônica Saúde (Online) ; 2(2): 51-64, 2011. graf, ilus
Artigo em Português | Coleciona SUS | ID: biblio-945982

Documentos relacionados

  1. Immune response to dengue virus and prospects for a vaccine.
  2. A Dengue Vaccine.
  3. Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.
  4. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control.
  5. Designing effective control of dengue with combined interventions.
  6. Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.
  7. Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.
  8. Immunogenicity of a Live Dengue Vaccine (TAK-003).
  9. The first licensed dengue vaccine: can it be used in travelers?
  10. Brazil's record dengue surge: why a vaccine campaign is unlikely to stop it.